Novartis gets CDSCO panel nod to study anticancer drug JDQ443 Dr. Divya Colin17 Dec 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Novartis, has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO panel opines Johnson and Johnson to submit details of anticancer drug Teclistamab nod in EU, US Roshni Dhar16 Dec 2022 5:20 PM ISTIn response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the...
Health Bulletin 16/December/2022 Dr. Nandita Mohan16 Dec 2022 4:40 PM ISTHere are the top health news for the day:NMC re-invites applications for establishment of new medical colleges, intake increase of MBBS, PG medical...
HC upholds 30 percent cap on trade margin of 42 anti-cancer drugs Farhat Nasim6 Dec 2022 10:30 AM ISTNew Delhi: Observing that if policy to make cancer medicine affordable is not promulgated, majority of the country's population will be vulnerable to...
Dr Reddys beats Aurobindo Pharma to become second biggest drug maker in India: Report Farhat Nasim22 Nov 2022 6:36 PM ISTNew Delhi: A change in the ranking of India's USD 50 billion pharma industry in over 7 years was witnessed as Hyderabad-based Dr Reddy's...
AstraZeneca tops quarterly estimates buoyed by cancer drug sales Ruchika Sharma13 Nov 2022 10:00 AM ISTDelaware: AstraZeneca on Thursday topped analysts' expectations for third-quarter profit and revenue, helped by sales of its key cancer drugs, and...
Novartis allows generic Leukemia drug production in 7 nations: Bloomberg Ruchika Sharma21 Oct 2022 2:35 PM ISTChronic myeloid leukemia is a cancer that starts in the blood-forming cells found in bone marrow, before spilling into the general blood stream.
Kerala HC directs Health Ministry, DoP to reply on unaffordability of patented cancer drug Ribociclib Roshni Dhar4 Oct 2022 4:49 PM ISTThe Kerala High Court has directed the Department of Pharmaceuticals (DoP) and a competent officer of Union Health Ministry to file their reply on the...
Health Bulletin 3/October/2022 Roshni Dhar3 Oct 2022 5:24 PM ISTHere are the top health news for the day:NMC seeks report on suicides by medicos, directs institutes to submit data Taking cognizance of the...
Kerala HC directs Health Ministry, DoP to reply on unaffordability of patented cancer drug Ribociclib Farhat Nasim2 Oct 2022 4:00 PM ISTThiruvananthapuram: The Kerala High Court has directed the Department of Pharmaceuticals (DoP) and a competent officer of Union Health Ministry to...
New device discovered by scientists to measure changing size of tumors below skin Roshni Dhar18 Sept 2022 3:51 PM ISTEngineers at the Georgia Institute of Technology and Stanford University have developed a small, self-contained device with a...
Trademark Infringement: Delhi HC rejects Sun Pharma plea against Hetero over cancer drug Letroz Roshni Dhar9 Sept 2022 3:43 PM ISTHolding that when the name is derived or coined from the name of the principal ingredient being used in the manufacture of the drug, no...
